Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Synthetic Human Secretin in Children With Autism

This study has been completed.
Information provided by:
Repligen Corporation Identifier:
First received: May 8, 2002
Last updated: August 4, 2005
Last verified: August 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2004
  Estimated Primary Completion Date: No date given